FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 40, Pages 29105-29114
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-08-20
DOI
10.1074/jbc.m113.510933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p21-Activated Kinase 1 Coordinates Aberrant Cell Survival and Pericellular Proteolysis in a Three-Dimensional Culture Model for Premalignant Progression of Human Breast Cancer
- (2015) Quanwen Li et al. NEOPLASIA
- Pak1 Kinase Links ErbB2 to -Catenin in Transformation of Breast Epithelial Cells
- (2013) L. E. Arias-Romero et al. CANCER RESEARCH
- The Art of Filling Protein Pockets Efficiently with Octahedral Metal Complexes
- (2012) Sebastian Blanck et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model
- (2012) H. Y. Chow et al. CANCER RESEARCH
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
- (2011) Y Shrestha et al. ONCOGENE
- Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
- (2011) C. C. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
- (2010) Hon Kit Wong et al. CANCER RESEARCH
- Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
- (2010) Ivan Stamenkovic et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- A novel imaging-compatible sciatic nerve schwannoma model
- (2010) Okay Saydam et al. JOURNAL OF NEUROSCIENCE METHODS
- p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2
- (2010) Hoi Yee Chow et al. PLoS One
- Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
- (2010) B. W. Murray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pak protein kinases and their role in cancer
- (2009) Bettina Dummler et al. CANCER AND METASTASIS REVIEWS
- Erbin and the NF2 Tumor Suppressor Merlin Cooperatively Regulate Cell-Type-Specific Activation of PAK2 by TGF-β
- (2009) Mark C. Wilkes et al. DEVELOPMENTAL CELL
- PAK kinase regulates Rac GTPase and is a potential target in human schwannomas
- (2009) Christine Flaiz et al. EXPERIMENTAL NEUROLOGY
- Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
- (2009) Fabio Zuccotto et al. JOURNAL OF MEDICINAL CHEMISTRY
- PAK signaling in oncogenesis
- (2009) P R Molli et al. ONCOGENE
- Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells
- (2008) A. S. McDaniel et al. BLOOD
- Validation of the p21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2
- (2008) C. Yi et al. CANCER RESEARCH
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
- (2008) Feng-Chun Yang et al. CELL
- Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes
- (2008) Jasna Maksimoska et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started